Clinical trials: Methemoglobinemia
- Condition Methemoglobinemia
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Acquired Methaemoglobinaemia
MEthylene Blue In Patients With Acquired Methemoglobinemia
This is an open label, uncontrolled, Phase 4 study including 10 patients who present in hospital/urgent care setting with acquired methemoglobinemia.
- Trial name
- MEBIPAM (NCT03395223)
- Testing
- Methylene Blue
- Where
- France
- Volunteers
- 7 people
- Sponsor
- Provepharm SAS